1994
DOI: 10.1038/bjc.1994.367
|View full text |Cite
|
Sign up to set email alerts
|

Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

1997
1997
2011
2011

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(5 citation statements)
references
References 51 publications
0
5
0
Order By: Relevance
“…This observation might suggest presence of mutations in the p53 tumour suppressor gene in these tumours, as p53 overexpression has been linked to certain p53 mutations ( Benjamin et al , 2008 ; Kusters-Vandevelde et al , 2010 ). However, a high level of detectable p53 protein has also been observed without detectable p53 mutations ( Stark et al , 1994 ).…”
Section: Discussionmentioning
confidence: 99%
“…This observation might suggest presence of mutations in the p53 tumour suppressor gene in these tumours, as p53 overexpression has been linked to certain p53 mutations ( Benjamin et al , 2008 ; Kusters-Vandevelde et al , 2010 ). However, a high level of detectable p53 protein has also been observed without detectable p53 mutations ( Stark et al , 1994 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, in contrast to their reports, our study showed a higher prevalence of p53, and more extensive p53 immunoreactivity, in DEKs from RTRs compared to similar lesions from the general population. 16,17 Assuming that accumulation of p53 does, in fact, represent an important step in tumor progression, 18 it is possible that our results may indicate an easier progression of premalignant lesions to SCC in RTRs than in ICIs. This might explain the increased incidence of skin cancer in renal transplant recipients.…”
Section: Discussionmentioning
confidence: 88%
“…Point mutations are seen in early stages of skin cancer; allelic loss enhances tumor growth with high exposure to UV radiation and enhances progression of the malignancy 9 . p53 mutations have also been seen in the SCCs of renal allograft recipients, present in approximately 56% of SCCs according to Stark and colleagues 10 …”
Section: Etiologymentioning
confidence: 99%